Navigating the Complex Regulatory Landscape for Cannabinoid Research: Governance, Policies, & Pathways
Time: 1:15 pm
day: Pre-Conference Day
Details:
From managing chronic pain to treating epilepsy, cannabinoids offer promising avenues for medical breakthroughs. However, their complex legal and regulatory status has created a dynamic landscape that researchers, policymakers, and pharmaceutical companies must navigate.
Join this workshop to discuss the complex regulatory landscape for cannabinoid research, understand the key governance and policy challenges, and explore the pathways for successful drug development.
Address critical questions, such as:
- What is the impact of FDA pathways on cannabinoid drug approval?
- How can researchers and pharmaceutical companies manage regional restrictions, stigma, and differences between synthetic and phytocannabinoids?
- What are the essential considerations for clinical trial design, safety, efficacy, GMP compliance, and product quality?
- How can variations in global regulations be navigated and multinational trials harmonized to ensure consistent data quality and safety standards
